Detection of hemoglobin H disease by long molecule sequencing.
Li Y, Liang L, Qin T, Tian M.
J Clin Lab Anal. 2022 Oct;36(10):e24687. doi: 10.1002/jcla.24687. Epub 2022 Sep 4.
Disease burden, management strategies, and unmet needs in alpha-thalassemia due to hemoglobin H disease.
Lal A, Viprakasit V, Vichinsky E, Lai Y, Lu MY, Kattamis A.
Am J Hematol. 2024 Nov;99(11):2164-2177. doi: 10.1002/ajh.27440. Epub 2024 Jul 22.
Luspatercept for non-deletional hemoglobin H disease.
Yang YN, Chou YY, Cheng CN.
Pediatr Blood Cancer. 2024 Oct;71(10):e31224. doi: 10.1002/pbc.31224. Epub 2024 Jul 23.
Clinical and genetic characteristics of hemoglobin H disease in Iran.
Abolghasemi H, Kamfar S, Azarkeivan A, Karimi M, Keikhaei B, Abolghasemi F, Radfar MH, Eshghi P, Alavi S.
Pediatr Hematol Oncol. 2022 Sep;39(6):489-499. doi: 10.1080/08880018.2021.2017529. Epub 2021 Dec 24.
Hemoglobin H disease: not necessarily a benign disorder.
Chui DH, Fucharoen S, Chan V.
Blood. 2003 Feb 1;101(3):791-800. doi: 10.1182/blood-2002-07-1975. Epub 2002 Sep 12.
The Clinical Phenotypes of Alpha Thalassemia.
Lal A, Vichinsky E.
Hematol Oncol Clin North Am. 2023 Apr;37(2):327-339. doi: 10.1016/j.hoc.2022.12.004.
Telomere shortening correlates with disease severity in hemoglobin H disease patients.
Panjawatanan P, Charoenkwan P, Tantiworawit A, Strogatz D, Perry KE, Tuntiwechapikul W.
Blood Cells Mol Dis. 2021 Jul;89:102563. doi: 10.1016/j.bcmd.2021.102563. Epub 2021 Mar 26.
Weighing the evidence for newborn screening for Hemoglobin H disease.
Kemper AR, Knapp AA, Metterville DR, Comeau AM, Green NS, Perrin JM.
J Pediatr. 2011 May;158(5):780-3. doi: 10.1016/j.jpeds.2010.10.042. Epub 2010 Dec 16.
Association of hemoglobin H (HbH) disease with hemoglobin A1c and glycated albumin in diabetic and non-diabetic patients.
He D, Kuang W, Yang X, Xu M.
Clin Chem Lab Med. 2021 Jan 14;59(6):1127-1132. doi: 10.1515/cclm-2020-1563. Print 2021 May 26.
Alpha and beta thalassemia.
Muncie HL Jr, Campbell J.
Am Fam Physician. 2009 Aug 15;80(4):339-44.
